Analytical Data
-
Gene name
LDCC
- Application
-
Species
Escherichia coli
-
Source
E. coli
-
Tag
C- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P52095
-
Expression Region
1-713aa
-
Molecular Weight
82.6 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of LDCC (Lipid-Derived Protein Complex) recombinant proteins has gained significant attention due to their potential applications in various biotechnological and medical fields. LDCC proteins, which are vital components in cellular processes such as membrane organization, signal transduction, and cellular responses to environmental stimuli, serve as crucial tools for understanding complex biological mechanisms. The advancement of recombinant DNA technology allows for the production of these proteins in controlled environments, facilitating in-depth studies of their structure and function. Particularly, LDCC proteins are implicated in diseases such as cancer and neurodegenerative disorders, making them valuable targets for therapeutic development. Researchers aim to elucidate the underlying mechanisms of LDCC protein interactions and their roles in pathophysiological conditions. This knowledge can lead to innovative approaches in drug design and personalized medicine. Overall, the investigation of LDCC recombinant proteins not only enhances our understanding of fundamental biological processes but also paves the way for novel therapeutic strategies to combat various diseases.
